Viking Global Investors LP's Form 4 filing
Inhibrx Biosciences, Inc. (INBX) · filed Oct 9, 2025
- Accession no.
- 0000905148-25-003555
- Filed
- Oct 9, 2025, 4:41 PM ET
- Trade date
- Oct 7, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $11.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Viking Global Investors LPCIK 0001103804 | 10% Owner |
| Halvorsen Ole AndreasCIK 0001133006 | 10% Owner |
| Ott David C.CIK 0001621842 | 10% Owner |
| Viking Global Opportunities Portfolio GP LLCCIK 0001629472 | 10% Owner |
| Viking Global Opportunities GP LLCCIK 0001629476 | 10% Owner |
| Viking Global Opportunities Illiquid Investments Sub-Master LPCIK 0001629482 | 10% Owner |
| Shabet Rose SharonCIK 0001711393 | 10% Owner |
| Viking Global Opportunities Parent GP LLCCIK 0001886738 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Common Stock | SSaleDisposed | −308,643 | $32.25 | −$9,953,736.75 | 1,267,823 | Indirect | |
| Oct 7, 2025 | Common Stock | SSaleDisposed | −16,315 | $32.25 | −$526,158.75 | 67,018 | Indirect | |
| Oct 7, 2025 | Common Stock | SSaleDisposed | −25,042 | $32.25 | −$807,604.5 | 102,864 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.